Dermacyn® Irrigation in Reducing Infection of a Median Sternotomy Wound
Background: Sternal wound infection is an infrequent yet potentially devastating complication following sternotomy. Among the standard practices used as preventive measures are the use of prophylactic antibiotics and povidone-iodine as an irrigation agent. A new antiseptic agent, Dermacyn® super-oxidized water (Oculus Innovative Sciences), has recently been used as a wound-irrigation agent before the closure of sternotomy wounds.
Methods: This prospective, randomized clinical trial was conducted to compare the effectiveness of Dermacyn and povidone-iodine in reducing sternotomy wound infection in patients undergoing coronary artery bypass graft surgery. Upon chest closure and after insertion of sternal wires, wounds were soaked for 15 minutes with either Dermacyn or povidone-iodine. Subcutaneous tissue and skin were then closed routinely. Patients were followed up, and any wound infection was analyzed.
Results: Of the 178 patients, 88 patients were in the Dermacyn group, and 90 were in the povidone-iodine group. The mean (±SD) age of the patients was 61.1 ± 7.6 years. The incidence of sternotomy wound infection was 19 cases (10.7%). Five (5.7%) of these cases were from the Dermacyn group, and 14 (15.6%) were from the povidone-iodine group (P = .033). No Dermacyn-related complication was identified.
Conclusion: We found Dermacyn to be safe and more effective as a wound-irrigation agent than povidone-iodine for preventing sternotomy wound infection.
Bitkover CY, Gårdlund B. 1998. Mediastinitis after cardiovascular operations: a case-control study of risk factors. Ann Thorac Surg 65:36-40.nBlanchard A, Hurni M, Ruchat P, Stumpe F, Fischer A, Sadeghi H. 1995. Incidence of deep and superficial sternal infection after open heart surgery. A ten years retrospective study from 1981 to 1991. Eur J Cardiothorac Surg 9:153-7.nBongiovanni CM. 2006. Superoxidized water improves wound care outcomes in diabetic patients. Diabet Microvasc Complications Today May/June:11-4.nCarrier M, Grégoire J, Tronc F, Cartier R, Leclerc Y, Pelletier LC. 1992. Effect of internal mammary artery dissection on sternal vascularization. Ann Thorac Surg 53:115-9.nEl Oakley RM, Wright JE. 1996. Postoperative mediastinitis: classification and management. Ann Thorac Surg 61:1030-6.nGrossi EA, Esposito R, Harris LJ, et al. 1991. Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 102:342-6.nHirotani T, Shirota S, Cho Y, Takeuchi S. 2002. Feasibility and suitability of the routine use of bilateral internal thoracic arteries. Ann Thorac Surg 73:511-5.nHoran FC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. 1992. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606-8.nLanda-Solis C, González-Espinosa D, Guzmán-Soriano B, et al. 2005. Microcyn: a novel super-oxidized water with neutral pH and disinfectant activity. J Hosp Infect 61:291-9.nLoop FD, Lytle BW, Cosgrove DM, et al. 1990. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 49:179-87.nMoulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. 1996. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation 94(suppl):II87-92.nOculus Innovative Sciences. 2006. Technical description of DERMA-CYN™. Microcyn™ Technology, Inc. Petaluma, Calif.: Oculus Innovative Sciences.nOhno H, Higashidate M, Yokosuka T. 2000. Mediastinal irrigation with superoxidized water in open-heart surgery: the safety and pitfalls of cardiovascular surgical application. Surg Today 30:1055-6.nOschner JL, Mills NL, Woolverton WC. 1972. Disruption and infection of median sternotomy incision. J Cardiovasc Surg 13:394-9.nPaola LD, Brocco E, Senesiet A, et al. 2006. Super-oxidized solution (SOS) therapy for infected diabetic foot ulcers. Wounds 18:262-70.nSofer D, Gurevitch J, Shapira I, et al. 1999. Sternal wound infections in patients after coronary artery bypass grafting using bilateral skeletonized internal mammary arteries. Ann Surg 229:585-90.nUlicny KS Jr, Hiratzka LF. 1991. The risk factors of median sternotomy infection: a current review. J Card Surg 6:338-51.nVegas AA, Jodra VM, García ML. 1993. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and directs cost of hospitalization. Eur J Epidemiol 9:504-10.nZacharias A, Habib RH. 1996. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 110:1173-8.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).